SMARCA4 and Barrett esophagus: In contrast, mutations in ARID1A and SMARCA4, while they are believed to be positively selected in BE overall based on an excess of functional mutations over expectations, do not achieve large‐scale spreading; we posit that their selective advantage does not apply during initial expansion and that SMARCA4 mutations may in fact be disadvantageous during this phase.